Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-214' Or cancer = '' Total: 60 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-214 bladder cancer down MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer.
hsa-mir-214 breast cancer down Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
hsa-mir-214 breast cancer down miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade.
hsa-mir-214 breast cancer down MiR-214 negatively regulates proliferation and WNT/?-catenin signaling in breast cancer.
hsa-mir-214 cervical cancer down MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-?-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.
hsa-mir-214 cervical cancer down Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.
hsa-mir-214 cervical cancer down MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells.
hsa-mir-214 cervical cancer down MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.
hsa-mir-214 cervical squamous cell carcinoma down Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.
hsa-mir-214 colon cancer down [Expression and proliferative regulation of miR-204 related to mitochondrial transcription factor A in colon cancer].
hsa-mir-214 colon cancer down microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2.
hsa-mir-214 colorectal cancer down The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.
hsa-mir-214 esophageal cancer down Regulation of ?-catenin-mediated esophageal cancer growth and invasion by miR-214.
hsa-mir-214 esophageal cancer up LncRNA BDNF-AS inhibits proliferation, migration, invasion and EMT in oesophageal cancer cells by targeting miR-214.
hsa-mir-214 esophageal squamous cell carcinoma down MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma.
hsa-mir-214 esophageal squamous cell carcinoma down miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
hsa-mir-214 gastric cancer up miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
hsa-mir-214 gastric cancer up Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein.
hsa-mir-214 gastric cancer up Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis.
hsa-mir-214 gastric cancer up Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer.
hsa-mir-214 gastric cancer up MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer.
hsa-mir-214 gastric cancer up MicroRNA-214 promotes the proliferation, migration and invasion of gastric cancer MKN28 cells by suppressing the expression of Dact2.
hsa-mir-214 glioma up Associations between the Expression of micro-RNA 214 and clinicopathologic parameters of glioma.
hsa-mir-214 glioma down miRNA-214 inhibits cellular proliferation and migration in glioma cells targeting caspase-1 involved in pyroptosis.
hsa-mir-214 hepatocellular carcinoma down MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3.
hsa-mir-214 hepatocellular carcinoma up MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.
hsa-mir-214 hepatocellular carcinoma down MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of ?-catenin.
hsa-mir-214 hepatocellular carcinoma down Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.
hsa-mir-214 hepatocellular carcinoma down Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma.
hsa-mir-214 hepatocellular carcinoma down miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
hsa-mir-214 hepatocellular carcinoma down Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
hsa-mir-214 hepatocellular carcinoma down Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.
hsa-mir-214 lung adenocarcinoma up microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu).
hsa-mir-214 lung adenocarcinoma up TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
hsa-mir-214 lung cancer down microRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D.
hsa-mir-214 malignant melanoma up Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
hsa-mir-214 malignant melanoma up Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.
hsa-mir-214 multiple myeloma down Restoration of miR-214 expression reduces growth of myeloma cells through a positive regulation of P53 and inhibition of DNA replication.
hsa-mir-214 nasopharyngeal carcinoma up miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
hsa-mir-214 nasopharyngeal carcinoma up Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma.
hsa-mir-214 non-small cell lung cancer up Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
hsa-mir-214 oral cancer up MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5.
hsa-mir-214 osteosarcoma up MicroRNA-214 functions as an oncogene in human osteosarcoma by targeting TRAF3.
hsa-mir-214 osteosarcoma up Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
hsa-mir-214 ovarian cancer up Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research.
hsa-mir-214 ovarian cancer down MicroRNA-214 Suppresses Ovarian Cancer by Targeting ?-Catenin.
hsa-mir-214 ovarian cancer down MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D.
hsa-mir-214 pancreatic cancer down Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-214 pancreatic cancer up Dysregulation of miR-15a and miR-214 in human pancreatic cancer.
hsa-mir-214 primary cns lymphomas down Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
hsa-mir-214 renal cell carcinoma down microRNA-214 Reduces IGF-1 Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.
hsa-mir-214-3p breast cancer up Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
hsa-mir-214-3p esophageal cancer down Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
hsa-mir-214-3p gastric cancer up The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer.
hsa-mir-214-3p hepatocellular carcinoma down LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p.
hsa-mir-214-3p hepatocellular carcinoma down MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.
hsa-mir-214-3p hepatocellular carcinoma down Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
hsa-mir-214-5p glioblastoma up Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5.
hsa-mir-214-5p hepatocellular carcinoma down MicroRNA-214-5p Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Targeting Wiskott-Aldrich Syndrome Like.
hsa-mir-214-5p hepatocellular carcinoma down miR-214-5p targets KLF5 and suppresses proliferation of human hepatocellular carcinoma cells.